E-LIB Suche - Ergebnisse für: Sophie Fürst

1

MTA1 as negative prognostic marker in vulvar carcinoma:

Wanka, Giulia ; Jueckstock, Julia ; Wild, Carl Mathis...
Journal of Cancer Research and Clinical Oncology. 149 (2023) 9 - p. 6191-6201 , 2023

Link: https://doi.org/10.1007/..

2

Prostaglandin E2 receptor EP1 expression in vulvar cancer:

Buchholz, Anna ; Vattai, Aurelia ; Fürst, Sophie...
Journal of Cancer Research and Clinical Oncology. 149 (2022) 8 - p. 5369-5376 , 2022

Link: https://doi.org/10.1007/..

3

T-Cell Density at the Invasive Margin and Immune Phenotypes..:

Burandt, Eike ; Blessin, Niclas C. ; Rolschewski, Ann-Christin...
Cancers. 14 (2022) 17 - p. 4246 , 2022

Link: https://doi.org/10.3390/..

4

Programm zur Früherkennung von Zervixkarzinomen:

Kunstein, Ariane ; Fürst, Sophie ; Röbl-Mathieu, Marianne.
MMW - Fortschritte der Medizin. 164 (2022) 16 - p. 42-45 , 2022

Link: https://doi.org/10.1007/..

5

EP4 as a Negative Prognostic Factor in Patients with Vulvar..:

Buchholz, Anna ; Vattai, Aurelia ; Fürst, Sophie...
Cancers. 13 (2021) 6 - p. 1410 , 2021

Link: https://doi.org/10.3390/..

6

Cytoplasmic VDR expression as an independent risk factor fo..:

Czogalla, Bastian ; Deuster, Eileen ; Liao, Yue...
Histochemistry and Cell Biology. 154 (2020) 4 - p. 421-429 , 2020

Link: https://doi.org/10.1007/..

7

Predicting the course of disease in recurrent vulvar cancer..:

Woelber, Linn ; Eulenburg, Christine ; Kosse, Jens...
Gynecologic Oncology. 154 (2019) 3 - p. 571-576 , 2019

Link: https://doi.org/10.1016/..

8

Peri-operative oral immunonutrition in malnourished ovarian..:

Hertlein, Linda ; Zeder-Göß, Christine ; Fürst, Sophie...
Archives of Gynecology and Obstetrics. 297 (2018) 6 - p. 1533-1538 , 2018

Link: https://doi.org/10.1007/..

9

Malnutrition and clinical outcome in gynecologic patients:

Hertlein, Linda ; Kirschenhofer, Angela ; Fürst, Sophie...
European Journal of Obstetrics & Gynecology and Reproductive Biology. 174 (2014) - p. 137-140 , 2014

Link: https://doi.org/10.1016/..

10

Uterusmyome: Wann ist therapeutisches Eingreifen angesagt?:..:

Fürst, Sophie ; Lenhard, Miriam ; Burges, Alexander.
MMW - Fortschritte der Medizin. 154 (2012) 20 - p. 61-64 , 2012

Link: https://doi.org/10.1007/..

11

Human epididymis protein 4 (HE4) in benign and malignant di..:

Hertlein, Linda ; Stieber, Petra ; Kirschenhofer, Angela...
Clinical Chemistry and Laboratory Medicine (CCLM). 50 (2012) 12 - p. 2181-2188 , 2012

Link: https://doi.org/10.1515/..

12

The diagnostic accuracy of two human epididymis protein 4 (..:

Lenhard, Miriam ; Stieber, Petra ; Hertlein, Linda...
Clinical Chemistry and Laboratory Medicine (CCLM). 49 (2011) 12 - p. , 2011

Link: https://doi.org/10.1515/..

13

Predictive factors for lymph node metastases in vulvar canc..:

Klapdor, Rüdiger ; Wölber, Linn ; Hanker, Lars...
Gynecologic Oncology. 154 (2019) 3 - p. 565-570 , 2019

Link: https://doi.org/10.1016/..

14

Lymph node ratio in inguinal lymphadenectomy for squamous c..:

Polterauer, Stephan ; Schwameis, Richard ; Grimm, Christoph...
Gynecologic Oncology. 153 (2019) 2 - p. 286-291 , 2019

Link: https://doi.org/10.1016/..

15

Outcome After Sentinel Lymph Node Dissection in Vulvar Canc..:

Klapdor, Rüdiger ; Hillemanns, Peter ; Wölber, Linn...
Annals of Surgical Oncology. 24 (2016) 5 - p. 1314-1321 , 2016

Link: https://doi.org/10.1245/..